{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:51:20Z","timestamp":1791165080182,"version":"4.1.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12035-014-8735-4","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T09:46:28Z","timestamp":1400492788000},"page":"331-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Activation of IGF-1 and Insulin Signaling Pathways Ameliorate Mitochondrial Function and Energy Metabolism in Huntington\u2019s Disease Human Lymphoblasts"],"prefix":"10.1007","volume":"51","author":[{"given":"Luana","family":"Naia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Lu\u00edsa","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Cunha-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana R.","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio N.","family":"La\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Saudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Cristina","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"key":"8735_CR1","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington\u2019s disease. Eur J Neurosci 27:2803\u20132820","journal-title":"Eur J Neurosci"},{"key":"8735_CR2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2009","unstructured":"Zuccato C, Valenza M, Cattaneo E (2009) Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev 90:905\u2013981","journal-title":"Physiol Rev"},{"key":"8735_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/NMM:4:1-2:7","volume":"4","author":"ME MacDonald","year":"2003","unstructured":"MacDonald ME, Gines S, Gusella JF, Wheeler VC (2003) Huntington\u2019s disease. NeuroMolecular Med 4:7\u201320","journal-title":"NeuroMolecular Med"},{"key":"8735_CR4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"8735_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S (2001) Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci 24:182\u2013188","journal-title":"Trends Neurosci"},{"key":"8735_CR6","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.freeradbiomed.2012.09.004","volume":"53","author":"M Ribeiro","year":"2012","unstructured":"Ribeiro M, Rosenstock TR, Cunha-Oliveira T, Ferreira IL, Oliveira CR, Rego AC (2012) Glutatione redox cycle dysregulation in Huntington\u2019s disease knock-in striatal cells. Free Radic Biol Med 53:1857\u20131867","journal-title":"Free Radic Biol Med"},{"key":"8735_CR7","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Hum Mol Genet 19:3919\u20133935","journal-title":"Hum Mol Genet"},{"key":"8735_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389450111007011218","volume":"11","author":"TR Rosenstock","year":"2010","unstructured":"Rosenstock TR, Duarte AI, Rego AC (2010) Mitochondrial-Associated Metabolic Changes and Neurodegeneration in Huntington's disease\u2014from Clinical Features to the Bench. Curr Drug Targets 11:1\u201316","journal-title":"Curr Drug Targets"},{"key":"8735_CR9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2008.07.009","volume":"374","author":"S Almeida","year":"2008","unstructured":"Almeida S, Sarmento-Ribeiro AB, Janu\u00e1rio C, Rego AC, Oliveira CR (2008) Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients. Biochem Biophys Res Commun 374:599\u2013603","journal-title":"Biochem Biophys Res Commun"},{"key":"8735_CR10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.410080408","volume":"8","author":"JW Pettegrew","year":"1980","unstructured":"Pettegrew JW, Nichols JS, Stewart RM (1980) Membrane studies in Huntington's disease: steady-state fluorescence studies of intact erythrocytes. Ann Neurol 8:381\u2013386","journal-title":"Ann Neurol"},{"key":"8735_CR11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","volume":"5","author":"A Sawa","year":"1999","unstructured":"Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF Jr, Greenamyre JT, Snyder SH, Ross CA (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5:1194\u20131198","journal-title":"Nat Med"},{"key":"8735_CR12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.mito.2013.05.006","volume":"13","author":"AC Silva","year":"2013","unstructured":"Silva AC, Almeida S, La\u00e7o M, Duarte AI, Domingues J, Oliveira CR, Janu\u00e1rio C, Rego AC (2013) Mitochondrial respiratory chain complex activity and bioenergetics alterations in human platelets derived from pre-symptomatic and symptomatic Huntington\u2019s disease carriers. Mitochondrion 13:801\u2013809","journal-title":"Mitochondrion"},{"key":"8735_CR13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.expneurol.2009.05.012","volume":"219","author":"J Sassone","year":"2009","unstructured":"Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A (2009) Huntington's disease: the current state of research with peripheral tissues. Exp Neurol 219:385\u2013397","journal-title":"Exp Neurol"},{"key":"8735_CR14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 39:385\u2013389","journal-title":"Ann Neurol"},{"key":"8735_CR15","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","volume":"43","author":"BG Jenkins","year":"1993","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993) Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 43:2689\u20132695","journal-title":"Neurology"},{"key":"8735_CR16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","volume":"48","author":"R Lodi","year":"2000","unstructured":"Lodi R, Schapira AH, Manners D, Styles P, Wood NW, Taylor DJ, Warner TT (2000) Abnormal in vivo skeletal muscle energy metabolism in Huntington\u2019s disease and dentatorubropallidoluysian atrophy. Ann Neurol 48:72\u201376","journal-title":"Ann Neurol"},{"key":"8735_CR17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","volume":"17","author":"W Song","year":"2011","unstructured":"Song W, Chen J, Petrilli A et al (2011) Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 17:377\u2013382","journal-title":"Nat Med"},{"key":"8735_CR18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2010.01.002","volume":"222","author":"IL Ferreira","year":"2010","unstructured":"Ferreira IL, Nascimento MV, Ribeiro M, Almeida S, Cardoso SM, Grazina M, Pratas J, Santos MJ, Janu\u00e1rio C, Oliveira CR, Rego AC (2010) Mitochondrial-dependent apoptosis in Huntington's disease human cybrids. Exp Neurol 222:243\u2013255","journal-title":"Exp Neurol"},{"key":"8735_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","volume":"231","author":"IL Ferreira","year":"2011","unstructured":"Ferreira IL, Cunha-Oliveira T, Nascimento MV, Ribeiro M, Proen\u00e7a MT, Janu\u00e1rio C, Oliveira CR, Rego AC (2011) Bioenergetics dysfunction in Huntington\u2019s disease human cybrids. Exp Neurol 231:127\u2013134","journal-title":"Exp Neurol"},{"key":"8735_CR20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exger.2006.08.009","volume":"42","author":"GM Cole","year":"2007","unstructured":"Cole GM, Frautschy SA (2007) The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's disease. Exp Gerontol 42:10\u201321","journal-title":"Exp Gerontol"},{"key":"8735_CR21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","volume":"2","author":"S Humbert","year":"2002","unstructured":"Humbert S, Bryson EA, Cordelieres FP, Connors NC, Datta SR, Finkbeiner S, Greenberg ME, Saudou F (2002) The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2:831\u2013837","journal-title":"Dev Cell"},{"key":"8735_CR22","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.freeradbiomed.2005.05.002","volume":"39","author":"AI Duarte","year":"2005","unstructured":"Duarte AI, Santos MS, Oliveira CR, Rego AC (2005) Insulin neuroprotection against oxidative stress in cortical neurons\u2014involvement of uric acid and glutathione antioxidant defences. Free Radic Biol Med 39:876\u2013889","journal-title":"Free Radic Biol Med"},{"key":"8735_CR23","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db06-0030","volume":"55","author":"AI Duarte","year":"2006","unstructured":"Duarte AI, Proenca T, Oliveira CR, Santos MS, Rego AC (2006) Insulin restores metabolic function in cultured cortical neurons subjected to oxidative stress. Diabetes 55:2863\u20132870","journal-title":"Diabetes"},{"key":"8735_CR24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbamcr.2008.02.016","volume":"1783","author":"AI Duarte","year":"2008","unstructured":"Duarte AI, Santos P, Oliveira CR, Santos MS, Rego AC (2008) Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3\u03b2 signaling pathways and changes in protein expression. Biochim Biophys Acta 1783:994\u20131002","journal-title":"Biochim Biophys Acta"},{"key":"8735_CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/mol.62.2.225","volume":"62","author":"WH Zheng","year":"2002","unstructured":"Zheng WH, Kar S, Quirion R (2002) Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase\/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. Mol Pharmacol 62:225\u2013233","journal-title":"Mol Pharmacol"},{"key":"8735_CR26","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1523\/JNEUROSCI.20-08-02896.2000","volume":"20","author":"MA Aberg","year":"2000","unstructured":"Aberg MA, Aberg ND, Hedb\u00e4cker H, Oscarsson J, Eriksson PS (2000) Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20:2896\u20132903","journal-title":"J Neurosci"},{"key":"8735_CR27","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1523\/JNEUROSCI.21-05-01628.2001","volume":"21","author":"JL Trejo","year":"2001","unstructured":"Trejo JL, Carro E, Torres-Aleman I (2001) Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 21:1628\u20131634","journal-title":"J Neurosci"},{"key":"8735_CR28","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/jcp.24334","volume":"228","author":"L Sasone","year":"2013","unstructured":"Sasone L, Reali V, Pellegrini L, Villanova L, Aventaggiato M, Marfe G, Rosa R, Nebbioso M, Tafani M, Fini M, Russo MA, Pucci B (2013) SIRT1 silencing confers neuroprotection through IGF-1 pathway activation. J Cell Physiol 228:1754\u20131761","journal-title":"J Cell Physiol"},{"key":"8735_CR29","doi-asserted-by":"crossref","first-page":"e64015","DOI":"10.1371\/journal.pone.0064015","volume":"8","author":"HC Chang","year":"2013","unstructured":"Chang HC, Yang YR, Wang PS, Kuo CH, Wang RY (2013) The neuroprotective effects of intramuscular insulin-like growth factor-I treatment in brain ischemic rats. PLoS One 8:e64015","journal-title":"PLoS One"},{"key":"8735_CR30","doi-asserted-by":"crossref","unstructured":"Lopes C, Ribeiro M, Duarte AI, Humbert S, Saudou F, Pereira de Almeida L, Hayden M, Rego AC (2014) IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice. Mol Neurobiol 49:1126\u20131142","DOI":"10.1007\/s12035-013-8585-5"},{"key":"8735_CR31","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","volume":"19","author":"MA Pouladi","year":"2010","unstructured":"Pouladi MA, Xie Y, Skotte NH et al (2010) Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum Mol Genet 19:1528\u20131538","journal-title":"Hum Mol Genet"},{"key":"8735_CR32","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"A Dalrymple","year":"2007","unstructured":"Dalrymple A, Wild EJ, Joubert R et al (2007) Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 6:2833\u20132840","journal-title":"J Proteome Res"},{"key":"8735_CR33","doi-asserted-by":"crossref","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","volume":"4","author":"N Saleh","year":"2009","unstructured":"Saleh N, Moutereau S, Durr A, Krystkowiak P, Azulay JP, Tranchant C, Broussolle E, Morin F, Bachoud-L\u00e9vi AC, Maison P (2009) Neuroendocrine disturbances in Huntington\u2019s disease. PLoS One 4:e4962","journal-title":"PLoS One"},{"key":"8735_CR34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0b013e3181e62076","volume":"75","author":"N Saleh","year":"2010","unstructured":"Saleh N, Moutereau S, Azulay JP, Verny C, Simonin C, Tranchant C, El Hawajri N, Bachoud-L\u00e9vi AC, Maison P (2010) High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology 75:57\u201363","journal-title":"Neurology"},{"key":"8735_CR35","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1172\/JCI46305","volume":"121","author":"M Sadagursky","year":"2011","unstructured":"Sadagursky M, Cheng Z, Rozzo A, Palazzolo I, Kelley GR, Dong X, Krainc D, White MF (2011) IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. J Clin Invest 121:4070\u20134081","journal-title":"J Clin Invest"},{"key":"8735_CR36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nbd.2004.07.002","volume":"17","author":"S Almeida","year":"2004","unstructured":"Almeida S, Domingues A, Rodrigues L, Oliveira CR, Rego AC (2004) FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures. Neurobiol Dis 17:435\u2013444","journal-title":"Neurobiol Dis"},{"key":"8735_CR37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0003-2697(85)90405-1","volume":"146","author":"V Stocchi","year":"1985","unstructured":"Stocchi V, Cucchiarini L, Magnani M, Chiarantini L, Palma P, Crescentini G (1985) Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells. Anal Biochem 146:118\u2013124","journal-title":"Anal Biochem"},{"key":"8735_CR38","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/B978-0-12-091304-6.50028-8","volume-title":"Methods of enzymatic analysis","author":"W Lamprecht","year":"1974","unstructured":"Lamprecht W, Stein P, Heinz F, Weissner H (1974) Creatine phosphate. In: Bergmeyer H (ed) Methods of enzymatic analysis, vol 4. Academic Press, New York, pp 1777\u20131781"},{"key":"8735_CR39","first-page":"79","volume-title":"Mitochondria, a practical approach","author":"CI Ragan","year":"1967","unstructured":"Ragan CI, Wilson MT, Darley-Usmar VM, Lowe PN (1967) Subfractionation of mitochondria and isolation of the proteins of oxidative phosphorylation. In: Darley-Usmar VM, Rickwood D, Wilson MT (eds) Mitochondria, a practical approach. IRL Press, London, pp 79\u2013112"},{"key":"8735_CR40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0076-6879(78)53008-5","volume":"53","author":"Y Hatefi","year":"1978","unstructured":"Hatefi Y, Stiggall DL (1978) Preparation and properties of succinate: ubiquinone oxidoreductase (complex II). Methods Enzymol 53:21\u201327","journal-title":"Methods Enzymol"},{"key":"8735_CR41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0076-6879(67)10048-7","volume":"10","author":"DC Wharton","year":"1967","unstructured":"Wharton DC, Tzagotoff A (1967) Cytochrome oxidase from beef heart mitochondria. Methods Enzymol 10:245\u2013250","journal-title":"Methods Enzymol"},{"key":"8735_CR42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/bj1250115","volume":"125","author":"HG Coore","year":"1971","unstructured":"Coore HG, Denton RM, Martin BR, Randle PJ (1971) Regulation of adipose tissue pyruvate dehydrogenase by insulin and others hormones. Biochem J 125:115\u2013127","journal-title":"Biochem J"},{"key":"8735_CR43","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1460-9568.2005.03985.x","volume":"21","author":"E Colin","year":"2005","unstructured":"Colin E, R\u00e9gulier E, Perrin V, D\u00fcrr A, Brice A, Aebischer P, De\u00e9glon N, Humbert S, Saudou F (2005) Akt is altered in an animal model of Huntington\u2019s disease and in patients. Eur J Neurosci 21:1478\u20131488","journal-title":"Eur J Neurosci"},{"key":"8735_CR44","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1152\/physiolgenomics.00085.2012","volume":"44","author":"BD Stamper","year":"2012","unstructured":"Stamper BD, Mecham B, Park SS, Wilkerson H, Farin FM, Bever RP, Bammler TK, Mangravite LM, Cunningham ML (2012) Transcriptome correlation analysis identifies two unique craniosynostosis subtypes associated with IRS1 activation. Physiol Genomics 44:1154\u20131163","journal-title":"Physiol Genomics"},{"key":"8735_CR45","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1210\/endo-107-5-1451","volume":"107","author":"MM Rechler","year":"1980","unstructured":"Rechler MM, Zapf J, Nissley SP, Froesch ER, Moses AC, Podskalny JM, Schilling EE, Humbel RE (1980) Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology 107:1451\u20131459","journal-title":"Endocrinology"},{"key":"8735_CR46","doi-asserted-by":"crossref","first-page":"17934","DOI":"10.1074\/jbc.274.25.17934","volume":"274","author":"SA Summers","year":"1999","unstructured":"Summers SA, Kao AW, Kohn AD, Backus GS, Roth RA, Pessin JE, BirnBaum MJ (1999) The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolismo. J Biol Chem 274:17934\u201317940","journal-title":"J Biol Chem"},{"key":"8735_CR47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj20031259","volume":"377","author":"A Cole","year":"2004","unstructured":"Cole A, Frame S, Cohen P (2004) Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. Biochem J 377:249\u2013255","journal-title":"Biochem J"},{"key":"8735_CR48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/(SICI)1097-0320(19961201)25:4<333::AID-CYTO4>3.0.CO;2-E","volume":"25","author":"A Macho","year":"1996","unstructured":"Macho A, Decaudin D, Castedo M, Hirsch T, Susin SA, Zamzami N, Kroemer G (1996) Chloromethyl-X-Rosamine is an aldehyde-fixable potential-sensitive fluorochrome for the detection of early apoptosis. Cytometry 25:333\u2013340","journal-title":"Cytometry"},{"key":"8735_CR49","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1091\/mbc.E07-05-0404","volume":"18","author":"BA Kaufman","year":"2007","unstructured":"Kaufman BA, Durisic N, Mativetsky JM, Costantino S, Hancock MA, Grutter P, Shoubridge EA (2007) The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures. Mol Biol Cell 18:3225\u20133236","journal-title":"Mol Biol Cell"},{"key":"8735_CR50","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1073\/pnas.061038798","volume":"98","author":"J Wang","year":"2001","unstructured":"Wang J, Silva JP, Gustafsson CM, Rustin P, Larsson NG (2001) Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci U S A 98:4038\u20134043","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8735_CR51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/rns.2011.060","volume":"23","author":"L Naia","year":"2011","unstructured":"Naia L, Ribeiro MJ, Rego AC (2011) Mitochondrial and metabolic-based protective strategies in Huntington\u2019s disease: the case of creatine and coenzyme Q. Rev Neurosci 23:13\u201328","journal-title":"Rev Neurosci"},{"key":"8735_CR52","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","volume":"63","author":"I Palazzolo","year":"2009","unstructured":"Palazzolo I, Stack C, Kong L, Musaro A, Adachi H, Katsuno M, Sobue G, Taylor JP, Sumner CJ, Fischbeck KH, Pennuto M (2009) Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 63:316\u2013328","journal-title":"Neuron"},{"key":"8735_CR53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddi443","volume":"15","author":"BL Apostol","year":"2006","unstructured":"Apostol BL, Illes K, Pallos J, Bodai L, Wu J, Strand A, Schweitzer ES, Olson JM, Kazantsev A, Marsh JL, Thompson LM (2006) Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1\/2 protects against mutant huntingtin-associated toxicity. Hum Mol Genet 15:273\u2013285","journal-title":"Hum Mol Genet"},{"key":"8735_CR54","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1093\/hmg\/ddn281","volume":"17","author":"D Zala","year":"2008","unstructured":"Zala D, Colin E, Rangone H, Liot G, Humbert S et al (2008) Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum Mol Genet 17:3837\u20133846","journal-title":"Hum Mol Genet"},{"key":"8735_CR55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mcn.2008.09.007","volume":"40","author":"SC Warby","year":"2009","unstructured":"Warby SC, Doty CN, Graham RK, Shively J, Singaraja RR et al (2009) Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments. Mol Cell Neurosci 40:121\u2013127","journal-title":"Mol Cell Neurosci"},{"key":"8735_CR56","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1523\/JNEUROSCI.1589-10.2010","volume":"30","author":"M Metzler","year":"2010","unstructured":"Metzler M, Gan L, Mazarei G, Graham RK, Liu L, Bissada N, Lu G, Leavitt BR, Hayden MR (2010) Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A. J Neurosci 30:14318\u201314329","journal-title":"J Neurosci"},{"key":"8735_CR57","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/hmg\/ddr023","volume":"20","author":"LS Havel","year":"2011","unstructured":"Havel LS, Wang CE, Wade B, Huang B, Li S et al (2011) Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation. Hum Mol Genet 20:1424\u20131437","journal-title":"Hum Mol Genet"},{"key":"8735_CR58","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","volume":"64","author":"X Gu","year":"2009","unstructured":"Gu X, Greiner ER, Mishra R, Kodali R, Osmand A et al (2009) Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron 64:828\u2013840","journal-title":"Neuron"},{"key":"8735_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2012.09.011","volume":"424","author":"R Mishra","year":"2012","unstructured":"Mishra R, Hoop CL, Kodali R, Sahoo B, van der Wel PC et al (2012) Serine phosphorylation suppresses huntingtin amyloid accumulation by altering protein aggregation properties. J Mol Biol 424:1\u201314","journal-title":"J Mol Biol"},{"key":"8735_CR60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2008.110","volume":"16","author":"S Sarkar","year":"2009","unstructured":"Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC (2009) Rapamycin and mTOR- independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ 16:46\u201356","journal-title":"Cell Death Differ"},{"key":"8735_CR61","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cmet.2008.03.002","volume":"7","author":"P Gulati","year":"2008","unstructured":"Gulati P, Gaspers LD, Dann SG, Joaquin M, Nobukuni T, Natt F, Kozma SC, Thomas AP, Thomas G (2008) Amino acids activate mTOR complex 1 via Ca2+\/CaM signaling to hVps34. Cell Metab 7:456\u2013465","journal-title":"Cell Metab"},{"key":"8735_CR62","doi-asserted-by":"crossref","first-page":"25485","DOI":"10.1074\/jbc.M501707200","volume":"280","author":"GG Chiang","year":"2005","unstructured":"Chiang GG, Abraham RT (2005) Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem 280:25485\u201325490","journal-title":"J Biol Chem"},{"key":"8735_CR63","doi-asserted-by":"crossref","first-page":"26089","DOI":"10.1074\/jbc.M504045200","volume":"280","author":"MK Holz","year":"2005","unstructured":"Holz MK, Blenis J (2005) Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J Biol Chem 280:26089\u201326093","journal-title":"J Biol Chem"},{"key":"8735_CR64","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","volume":"14","author":"IS Seong","year":"2005","unstructured":"Seong IS, Ivanova E, Lee J-M, Choo YS, Fossale E, Anderson M, Gusella JF, Laramie JM, Myers RH, Lesort M, MacDonald ME (2005) HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet 14:2871\u20132880","journal-title":"Hum Mol Genet"},{"key":"8735_CR65","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/hmg\/ddn404","volume":"18","author":"H Wang","year":"2009","unstructured":"Wang H, Lim PJ, Karbowski M, Monteiro MJ (2009) Effects of overexpression of Huntingtin proteins on mitochondrial integrity. Hum Mol Genet 18:737\u2013752","journal-title":"Hum Mol Genet"},{"key":"8735_CR66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","volume":"41","author":"WJ Koroshetz","year":"1997","unstructured":"Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF (1997) Energy metabolism defects in Huntington\u2019s disease and effects of coenzyme Q10. Ann Neurol 41:160\u2013165","journal-title":"Ann Neurol"},{"key":"8735_CR67","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736","journal-title":"Nat Neurosci"},{"key":"8735_CR68","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.nbd.2010.08.009","volume":"40","author":"K Josefsen","year":"2010","unstructured":"Josefsen K, Nielsen SM, Campos A, Seifert T, Hasholt L, Nielsen JE, N\u00f8rrem\u00f8lle A, Skotte NH, Secher NH, Quistorff B (2010) Reduced gluconeogenesis and lactate clearance in Huntington's disease. Neurobiol Dis 40:656\u2013662","journal-title":"Neurobiol Dis"},{"key":"8735_CR69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2007.05.035","volume":"263","author":"WR Martin","year":"2007","unstructured":"Martin WR, Wieler M, Hanstock CC (2007) Is brain lactate increased in Huntington's disease? J Neurol Sci 263:70\u201374","journal-title":"J Neurol Sci"},{"key":"8735_CR70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","volume":"29","author":"JM Burg van der","year":"2008","unstructured":"van der Burg JM, Bacos K, Wood NI et al (2008) Increased metabolism in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis 29:41\u201351","journal-title":"Neurobiol Dis"},{"key":"8735_CR71","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0609833104","volume":"104","author":"WJ Powers","year":"2007","unstructured":"Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Dorsey JV, Hershey T, Perlmutter JS (2007) Selective defect of in vivo glycolysis in early Huntington\u2019s disease striatum. Proc Natl Acad Sci U S A 104:2945\u20132949","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8735_CR72","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","volume":"281","author":"T Milakovic","year":"2006","unstructured":"Milakovic T, Quintanilla RA, Johnson GV (2006) Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences. J Biol Chem 281:34785\u201334795","journal-title":"J Biol Chem"},{"key":"8735_CR73","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/hmg\/ddl248","volume":"15","author":"A Solans","year":"2006","unstructured":"Solans A, Zambrano A, Rodr\u00edguez M, Barrientos A (2006) Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III. Hum Mol Genet 15:3063\u20133081","journal-title":"Hum Mol Genet"},{"key":"8735_CR74","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.E05-07-0607","volume":"17","author":"A Benchoua","year":"2006","unstructured":"Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, Saudou F, Elalouf JM, Hirsch E, Hantraye P (2006) Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell 17:1652\u20131663","journal-title":"Mol Biol Cell"},{"key":"8735_CR75","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrm2434","volume":"9","author":"YP Ow","year":"2008","unstructured":"Ow YP, Green DR, Hao Z, Mak TW (2008) Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 9:532\u2013542","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8735_CR76","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1074\/jbc.M805972200","volume":"284","author":"UD Vempati","year":"2009","unstructured":"Vempati UD, Han X, Moraes CT (2009) Lack of cytochrome c in mouse fibroblasts disrupts assembly\/stability of respiratory complexes I and IV. J Biol Chem 284:4383\u20134391","journal-title":"J Biol Chem"},{"key":"8735_CR77","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.1523\/JNEUROSCI.1957-08.2008","volume":"28","author":"Y Hayashi","year":"2008","unstructured":"Hayashi Y, Yoshida M, Yamato M et al (2008) Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J Neurosci 28:8624\u20138634","journal-title":"J Neurosci"},{"key":"8735_CR78","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.yexcr.2007.12.025","volume":"314","author":"S Reijonen","year":"2008","unstructured":"Reijonen S, Putkonen N, N\u00f8rrem\u00f8lle A, Lindholm D, Korhonen L (2008) Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins. Exp Cell Res 314:950\u2013960","journal-title":"Exp Cell Res"},{"key":"8735_CR79","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.neuint.2011.04.009","volume":"59","author":"TR Rosenstock","year":"2011","unstructured":"Rosenstock TR, Brito OM, Lombradi V, Louros S, Ribeiro M, Almeida S, Ferreira IL, Oliveira CR, Rego AC (2011) FK506 ameliorates cell death features in Huntington\u2019s disease striatal cell models. Neurochem Int 59:600\u2013609","journal-title":"Neurochem Int"},{"key":"8735_CR80","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1749-6632.1999.tb07856.x","volume":"893","author":"AV Panov","year":"1999","unstructured":"Panov AV, Obertone T, Bennett-Desmelik J, Greenamyre JT (1999) Ca(2+)-dependent permeability transition and complex I activity in lymphoblast mitochondria from normal individuals and patients with Huntington's or Alzheimer's disease. Ann N Y Acad Sci 893:365\u2013368","journal-title":"Ann N Y Acad Sci"},{"key":"8735_CR81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","volume":"16","author":"E Rockabrand","year":"2007","unstructured":"Rockabrand E, Slepko N, Pantalone A, Nukala VN, Kazantsev A, Marsh JL, Sullivan PG, Steffan JS, Sensi SL, Thompson LM (2007) The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet 16:61\u201377","journal-title":"Hum Mol Genet"},{"key":"8735_CR82","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1074\/jbc.M311604200","volume":"279","author":"C Ibarra","year":"2004","unstructured":"Ibarra C, Estrada M, Carrasco L, Chiong M, Liberona JL, Cardenas C, D\u00edaz-Arava G, Jaimovich E, Lavandero S (2004) Insulin-like growth factor-1 induces an inositol 1,4,5-triphosphate-dependent increase in nuclear and cytosolic calcium in cultured rat cardiac myocytes. J Biol Chem 279:7554\u20137565","journal-title":"J Biol Chem"},{"key":"8735_CR83","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/jcp.24298","volume":"228","author":"JA Vald\u00e9s","year":"2013","unstructured":"Vald\u00e9s JA, Flores S, Fuentes EN, Osorio-Fuentealbe C, Jaimovich E, Molina A (2013) IGF-1 induces IP(3) dependent calcium signal involved in the regulation of myostatin gene expression mediated by NFAT during myoblast differentiation. J Cell Physiol 228:1452\u20131463","journal-title":"J Cell Physiol"},{"key":"8735_CR84","doi-asserted-by":"crossref","first-page":"192","DOI":"10.18632\/aging.100296","volume":"3","author":"LS Steelman","year":"2011","unstructured":"Steelman LS, Chappell WH, Abrams SL et al (2011) Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy\u2014implications for cancer and aging. Aging (Albany NY) 3:192\u2013222","journal-title":"Aging (Albany NY)"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8735-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-8735-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8735-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T06:37:52Z","timestamp":1689230272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-8735-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["8735"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-8735-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,20]]}}}